VINC (Vincerx Pharma) OCF Margin %: 0.00% (As of Mar. 2025)


What is Vincerx Pharma OCF Margin %?

Vincerx Pharma VINC OCF Margin % is 0.00% as of Mar. 2025.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Vincerx Pharma's Cash Flow from Operations for the three months ended in Mar. 2025 was $-4.45 Mil. Vincerx Pharma's Revenue for the three months ended in Mar. 2025 was $0.00 Mil. Therefore, Vincerx Pharma's OCF Margin % for the quarter that ended in Mar. 2025 was 0.00%.

As of today, Vincerx Pharma's current OCF Yield % is -34,609.09%.

The historical rank and industry rank for Vincerx Pharma's OCF Margin % or its related term are showing as below:


VINC's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Vincerx Pharma OCF Margin % Related Terms

Vincerx Pharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for Vincerx Pharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vincerx Pharma OCF Margin % Chart

Vincerx Pharma Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Vincerx Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vincerx Pharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Vincerx Pharma's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-26.127/0
= %

Vincerx Pharma's OCF Margin for the quarter that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-4.454/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Vincerx Pharma (VINC) has a OCF Margin % of 0.00% as of Mar. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vincerx Pharma and its competitors.
Is Vincerx Pharma's OCF Margin % too high?
Vincerx Pharma's current OCF Margin % is 0.00%.
How does Vincerx Pharma's OCF Margin % compare to SYGGF and CNBX?
Vincerx Pharma's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vincerx Pharma and its competitors. Vincerx Pharma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vincerx Pharma stock overvalued right now?
Vincerx Pharma (VINC) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vincerx Pharma (VINC), the current OCF Margin % is 0.00% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vincerx Pharma Business Description

Address 1825 S. Grant Street, San Mateo, CA, USA, 94402
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.